StreetInsider.com News Articles

CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework

Tue, 08 Sep 2026 17:00:00 -0400

Legislation delays implementation of new federal hemp restrictions until December 11, 2026, preserving continued access to naturally derived hemp products

SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today welcomed the enactment of federal legislation that delays implementation of significant changes to the federal definition of hemp and provides additional time for Congress and the Administration to develop a comprehensive

CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework

Tue, 08 Sep 2026 17:00:00 -0400

Legislation delays implementation of new federal hemp restrictions until December 11, 2026, preserving continued access to naturally derived hemp products

Form 10-Q CV Sciences, Inc. For: Jun 30

Thu, 13 Aug 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260813/26921231.html

Form 10-Q CV Sciences, Inc. For: Jun 30

Thu, 13 Aug 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260813/26921231.html

Form 8-K CV Sciences, Inc. For: May 14

Thu, 13 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260813/26920722.html

Form 8-K CV Sciences, Inc. For: May 14

Thu, 13 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260813/26920722.html

CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results

Thu, 13 Aug 2026 16:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / August 13, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2026.

Second Quarter 2026 and Recent Financial, Operating and Regulatory Highlights

Generated revenue of $3.0 million for the second quarter 2026 compared to $3.6 million for the second quarter 2025 and compared to $3.2 million for the first quarter 2026;
Recognized gross margin

CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results

Thu, 13 Aug 2026 16:00:00 -0400

Second Quarter 2026 and Recent Financial, Operating and Regulatory Highlights

Generated revenue of $3.0 million for the second quarter 2026 compared to $3.6 million for the second quarter 2025 and compared to $3.2 million for the first quarter 2026;
Recognized gross margin

CV Sciences launches new website for non-cannabinoid product line

Wed, 12 Aug 2026 02:58:13 -0400

CV Sciences, Inc. (OTCQB: CVSI) has launched PlusHLTH.com, a direct-to-consumer website dedicated to its +PlusHLTH™ product line of non-cannabinoid nutritional supplements, according to a company press release.

The San Diego-based company said the new site will serve as a separate digital home for the +PlusHLTH™ brand, while its existing PlusCBDOil.com site will continue to feature its hemp-derived CBD products.

The +PlusHLTH™ line currently includes dietary supplements in capsule and gummy formats, as well as Empowr, a plant-based protein product with creatine. CV Sciences said it plans to add new formulations and delivery formats to the line.

"Our launch of PlusHLTH.com marks an exciting

CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids

Tue, 11 Aug 2026 22:30:00 -0400

New digital destination brings the Company's Health Intelligence approach to life, helping consumers better understand their needs, discover science-backed solutions, and navigate healthy aging.

SAN DIEGO, CA / ACCESS Newswire / August 11, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "our", "us" or "we"), a consumer health company specializing in science-backed natural ingredients and products, today announced the launch of PlusHLTH.com, a new direct-to-consumer destination dedicated exclusively to the Company's growing +PlusHLTH™ product line.

The launch of PlusHLTH.com represents an important milestone in the Company's long-term strategy to expand beyond cannabinoids and

CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids

Tue, 11 Aug 2026 22:30:00 -0400

New digital destination brings the Company's Health Intelligence approach to life, helping consumers better understand their needs, discover science-backed solutions, and navigate healthy aging.

The launch of PlusHLTH.com represents an important milestone in the Company's long-term strategy to expand beyond cannabinoids and

Form 8-K CV Sciences, Inc. For: Mar 27

Thu, 04 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605879.html

Form 8-K CV Sciences, Inc. For: Mar 27

Thu, 04 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260604/26605879.html

Form 10-Q CV Sciences, Inc. For: Mar 31

Fri, 15 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260515/26505494.html

Form 10-Q CV Sciences, Inc. For: Mar 31

Fri, 15 May 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260515/26505494.html

CV Sciences (CVSI) Reports Q1 EPS of $0.00

Thu, 14 May 2026 16:06:59 -0400

CV Sciences (OTC: CVSI) reported Q1 EPS of $0.00. Revenue for the quarter came in at $3.2 million.

For earnings history and earnings-related data on CV Sciences (CVSI) click here.

Form 8-K CV Sciences, Inc. For: May 14

Thu, 14 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260514/26494600.html

Form 8-K CV Sciences, Inc. For: May 14

Thu, 14 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260514/26494600.html

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

Thu, 14 May 2026 16:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2026.

First Quarter 2026 and Recent Financial and Operating Highlights

Generated revenue of $3.2 million for the first quarter 2026 compared to $3.6 million for the first quarter 2025 and compared to $3.3 million for the fourth quarter 2025;
Recognized gross margin of

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

Thu, 14 May 2026 16:00:00 -0400

First Quarter 2026 and Recent Financial and Operating Highlights

Generated revenue of $3.2 million for the first quarter 2026 compared to $3.6 million for the first quarter 2025 and compared to $3.3 million for the fourth quarter 2025;
Recognized gross margin of

CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026

Tue, 12 May 2026 18:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the first quarter ended March 31, 2026, after the stock market closes on Thursday, May 14, 2026. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day.

The webcast

CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026

Tue, 12 May 2026 18:00:00 -0400

The webcast

Form DEF 14A CV Sciences, Inc. For: Apr 15

Wed, 15 Apr 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260415/26314219.html

Form DEF 14A CV Sciences, Inc. For: Apr 15

Wed, 15 Apr 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260415/26314219.html

Form 8-K CV Sciences, Inc. For: Apr 06

Fri, 10 Apr 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260410/26299875.html